Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

From X

@StableBread

Fajasy on X

Q2 2026 was the first quarter of positive FCF at Magna Mining $MGMNF (TSX: $NICU), but only because cash from March sales arrived in April. The quarter set Magna-era records for revenue and cash margin: → Revenue: US$21.5M, after the precious metals stream and higher smelting and refining charges. → Cash margin: Record US$6.4M, or US$1.41/payable lb, up from US$4.3M in Q1. → Operating cash flow: US$6.4M, including US$4.8M of March sales paid in April. → Free cash flow: US$3.7M, even though operating cash flow absorbed US$3.8M of exploration and evaluation spending, mostly at Levack, Magna’s flagship restart project. Adjusted for the US$4.8M of March sales paid in April, Q2 FCF was an outflow of ~US$1.2M, and H1 2026 as a whole was a US$10.5M outflow. At the mine level, McCreedy West (Magna’s producing mine) generated a US$10.8M cash margin in H1 2026, covering its US$3.6M of sustaining capital almost three times over. But Levack, corporate costs, interest, and working capital kept the company as a whole cash-negative. As of June 30, 2026, Magna held US$28.2M of cash. With net proceeds from Alpayana, the Peruvian mining group that bought 19.9% in August, the September deck puts cash at ~US$124M. Magna’s only debt is US$16.9M of unsecured 10% convertible notes due March 5, 2029, a third of which Dundee Corporation $DDEJF, a Toronto investment company, bought. They convert at CAD$2.00/share into 11.98M shares, or 3.8% of the current share count. Magna has funded itself mostly with equity, so the share count rose from 163.4M at the end of 2023 to 313.35M after Alpayana, up 91.8%. Options and share units add more. At June 30, Magna had 12.35M options at a weighted average exercise price of CAD$1.21 and 1.73M restricted and deferred share units. At CAD$2.45, 9.64M of the options are in the money, and exercising them would give Magna ~US$5.1M of cash. Counting the in-the-money options, the share units, and the notes, the diluted count is 336.70M (313.35M + 9.64M + 1.73M + 11.98M).
@BrokenMoats 2 clicks

Broken Moats on X

$DNA another perfectly rational move, happens daily across this low quality business, low quality balance sheet biotech tangential name space (ironically while actual biotech names sell off due to rates). My biggest question is why are these co. not raising $$$, all of them need money in this basket and their stock prices are up 100's% points in a very short period of time (few months). Wh not stretch the life of the company and fix the balance sheets?

Investor Letters

All letters

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Thursday Tailwinds #13: Nov 5, 2026

Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…

SUI $14B
Trade Ideas Flow 6 clicks

eToro: Expanding Beyond Crypto

EToro trades at 2.89x EV/FCF with $304 million in trailing free cash flow, expanding from crypto into equities, commodities, currencies and…

ETOR $1.9B
Max Arnoldi 5 clicks
CHWY · long

Chewy INC

Chewy (CHWY) is presented as a long opportunity after a prior 2022 short thesis played out.

CHWY $9.2B
Value Investors Club 5 clicks

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

AA $10BNKE $60B
Aurelion Research 4 clicks

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

CURB $3.6B
Real Assets, Real Value 5 clicks

Coupang: 3Q26 Business Recap

Coupang’s product-commerce growth rose 9% as data-leak effects fade, while management expects margins to return to pre-incident levels by…

CPNG $27B
Speedwell Memos 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 279

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.